Universal Cardiovascular Disease Risk Assessment in Pregnancy: Call to Action Expert Panel

Overview

Journal JACC Adv

Specialty Cardiology & Vascular Diseases

Date 2024 Oct 7

PMID 39372368

Authors

Afshan B Hameed

Maryam Tarsa

Cornelia R Graves

Anna Grodzinsky

Heike Thiel de Bocanegra

Diana S Wolfe

Affiliations

Soon will be listed here.

Abstract

The United States has the highest maternal mortality rate among developed countries, with cardiovascular disease (CVD) being one of the leading causes of maternal deaths. Diagnosing CVD during pregnancy may be challenging as symptoms of normal pregnancy overlap with those of CVD. Delays in recognition and response to the diagnosis of CVD is a missed opportunity for timely intervention to improve maternal outcomes. Implementing universal CVD risk assessment for all pregnant and postpartum patients across clinical care settings presents a pivotal opportunity to address this issue. Integrating a validated risk assessment tool into routine obstetric care, clinicians, including obstetricians, primary care, and emergency healthcare providers, can enhance awareness of cardiovascular risk and facilitate early CVD diagnosis. Consensus among stakeholders underscores the importance of screening and education on cardiovascular health strategies for pregnant and postpartum patients to reduce CVD-related maternal mortality. This comprehensive approach offers a pathway to identify at-risk individuals and intervene promptly, potentially saving lives and advancing maternal healthcare equity.

References

Heck J, Jones E, Bohn D, McCage S, Parker J, Parker M . Maternal Mortality Among American Indian/Alaska Native Women: A Scoping Review. J Womens Health (Larchmt). 2020; 30(2):220-229. DOI: 10.1089/jwh.2020.8890. View

Collier A, Molina R . Maternal Mortality in the United States: Updates on Trends, Causes, and Solutions. Neoreviews. 2019; 20(10):e561-e574. PMC: 7377107. DOI: 10.1542/neo.20-10-e561. View

Hameed A, Tarsa M, Graves C, Chang J, Billah M, Hatfield T . Cardiovascular Risk Assessment as a Quality Measure in the Pregnancy and Postpartum Period. JACC Adv. 2024; 2(1):100176. PMC: 11198421. DOI: 10.1016/j.jacadv.2022.100176. View

Hameed A, Haddock A, Wolfe D, Florio K, Drummond N, Allen C . Alliance for Innovation on Maternal Health: Consensus Bundle on Cardiac Conditions in Obstetric Care. Obstet Gynecol. 2023; 141(2):253-263. PMC: 9838734. DOI: 10.1097/AOG.0000000000005048. View

Silversides C, Grewal J, Mason J, Sermer M, Kiess M, Rychel V . Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study. J Am Coll Cardiol. 2018; 71(21):2419-2430. DOI: 10.1016/j.jacc.2018.02.076. View

Davis M, Walsh M . Cardio-Obstetrics. Circ Cardiovasc Qual Outcomes. 2019; 12(2):e005417. DOI: 10.1161/CIRCOUTCOMES.118.005417. View

Mehta L, Sharma G, Creanga A, Hameed A, Hollier L, Johnson J . Call to Action: Maternal Health and Saving Mothers: A Policy Statement From the American Heart Association. Circulation. 2021; 144(15):e251-e269. DOI: 10.1161/CIR.0000000000001000. View

Wolfe D, Hameed A, Taub C, Zaidi A, Bortnick A . Addressing maternal mortality: the pregnant cardiac patient. Am J Obstet Gynecol. 2018; 220(2):167.e1-167.e8. DOI: 10.1016/j.ajog.2018.09.035. View

Fleszar L, Bryant A, Johnson C, Blacker B, Aravkin A, Baumann M . Trends in State-Level Maternal Mortality by Racial and Ethnic Group in the United States. JAMA. 2023; 330(1):52-61. PMC: 10318476. DOI: 10.1001/jama.2023.9043. View

10.

Sliwa K, Hilfiker-Kleiner D, Petrie M, Mebazaa A, Pieske B, Buchmann E . Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010; 12(8):767-78. DOI: 10.1093/eurjhf/hfq120. View

11.

Sharma G, Kelliher A, Deen J, Parker T, Hagerty T, Choi E . Status of Maternal Cardiovascular Health in American Indian and Alaska Native Individuals: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2023; 16(6):e000117. DOI: 10.1161/HCQ.0000000000000117. View

12.

Pearson G, Veille J, RAHIMTOOLA S, Hsia J, Oakley C, Hosenpud J . Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000; 283(9):1183-8. DOI: 10.1001/jama.283.9.1183. View

13.

Lister R, Drake W, Scott B, Graves C . Black Maternal Mortality-The Elephant in the Room. World J Gynecol Womens Health. 2020; 3(1). PMC: 7384760. DOI: 10.33552/wjgwh.2019.03.000555. View

14.

Creanga A, Thoma M, MacDorman M . Value and disvalue of the pregnancy checkbox on death certificates in the United States-impact on newly released 2018 maternal mortality data. Am J Obstet Gynecol. 2020; 223(3):393.e1-393.e4. DOI: 10.1016/j.ajog.2020.05.046. View

15.

Fiori K, Belli H, Lauria M, Hirschhorn L, Schechter J, Hansman E . Implementing an integrated community based health systems strengthening approach to improve HIV survival in Northern Togo. AIDS Care. 2019; 32(6):705-713. PMC: 7357197. DOI: 10.1080/09540121.2019.1626342. View

16.

Epstein D, Garcia-Mochon L, Kaptoge S, Thompson S . Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature. Eur J Health Econ. 2015; 17(8):1041-1053. PMC: 5047941. DOI: 10.1007/s10198-015-0753-2. View

17.

Hameed A, Lawton E, McCain C, Morton C, Mitchell C, Main E . Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy. Am J Obstet Gynecol. 2015; 213(3):379.e1-10. DOI: 10.1016/j.ajog.2015.05.008. View

18.

Blumenthal E, Crosland B, Senderoff D, Santurino K, Garg N, Bernstein M . California Cardiovascular Screening Tool: Findings from Initial Implementation. AJP Rep. 2020; 10(4):e362-e368. PMC: 7669431. DOI: 10.1055/s-0040-1718382. View

19.

Gladstone R, Pudwell J, Pal R, Smith G . Referral to Cardiology Following Postpartum Cardiovascular Risk Screening at the Maternal Health Clinic in Kingston, Ontario. Can J Cardiol. 2019; 35(6):761-769. DOI: 10.1016/j.cjca.2019.03.008. View

20.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M . 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-3104. DOI: 10.1093/eurheartj/ehy339. View